Compounds > ruthenium
Page last updated: 2024-08-22

ruthenium and Angiogenesis, Pathologic

ruthenium has been researched along with Angiogenesis, Pathologic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, M; Cerón-Camacho, R; Coliat, P; Freund, JN; Gaiddon, C; Guenot, D; Guerin, E; Jung, AC; Le Lagadec, R; Licona, C; Mellitzer, G; Pfeffer, M; Sava, G; Venkatasamy, A; Vidimar, V1
Chen, L; Liu, J; Liu, Y; Qin, X; Sun, D; Yang, L; Yu, Q; Zhou, Y1
Clavel, CM; Dyson, PJ; Griffioen, AW; Nowak-Sliwinska, P; Păunescu, E; te Winkel, MT1
Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R1
Che, CM; Kwong, WL; Lai, YT; Lam, KY; Lee, PY; Lok, CN1
Brindell, M; Collet, G; Kieda, C; Oszajca, M; Stochel, G1
Bisland, SK; Flitney, FW; Fricker, SP; Hirst, DG; Kennovin, GD; Pritchard, RJ1

Other Studies

7 other study(ies) available for ruthenium and Angiogenesis, Pathologic

ArticleYear
A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53.
    Cancer letters, 2019, Volume: 440-441

    Topics: Animals; Antineoplastic Agents; Cisplatin; Colorectal Neoplasms; Female; HCT116 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds; Oxidation-Reduction; Ruthenium; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2019
Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles.
    Biomaterials, 2014, Volume: 35, Issue:5

    Topics: Animals; Cells, Cultured; Fluorescence; Hep G2 Cells; Heterografts; Humans; Liver Neoplasms; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Ruthenium; Selenium; Sulfhydryl Compounds

2014
Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
    Molecular pharmaceutics, 2015, Aug-03, Volume: 12, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Colorectal Neoplasms; Cymenes; Drug Screening Assays, Antitumor; Endothelium, Vascular; Female; HEK293 Cells; Humans; Immunoenzyme Techniques; Mice; Models, Molecular; Monoterpenes; Neovascularization, Pathologic; Organometallic Compounds; Ovarian Neoplasms; Ruthenium; Structure-Activity Relationship

2015
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
    Journal of inorganic biochemistry, 2016, Volume: 163

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays

2016
A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
    Angewandte Chemie (International ed. in English), 2016, 10-17, Volume: 55, Issue:43

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Macrocyclic Compounds; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neovascularization, Pathologic; Ruthenium; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Zebrafish

2016
Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016, Volume: 29, Issue:6

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Movement; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Gene Expression Regulation; Humans; Neovascularization, Pathologic; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Tumor Hypoxia

2016
Antitumor actions of ruthenium(III)-based nitric oxide scavengers and nitric oxide synthase inhibitors.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:9

    Topics: Animals; Enzyme Inhibitors; Free Radical Scavengers; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organometallic Compounds; Pentetic Acid; Rats; Ruthenium; Sarcoma, Experimental; Transplantation, Isogeneic; Tumor Burden

2011